Ambea
Market Cap
kr5.5b
Last Updated
2020/12/02 18:39 UTC
Data Sources
Company Financials +
Executive Summary
Ambea AB (publ) provides residential care services for people with special needs in Sweden and Norway. More Details
Rewards
Risk Analysis
Snowflake Analysis
Very undervalued with solid track record.
Similar Companies
Share Price & News
How has Ambea's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AMBEA is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: AMBEA's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
9.5%
AMBEA
3.8%
SE Healthcare
0.7%
SE Market
1 Year Return
-19.5%
AMBEA
11.1%
SE Healthcare
17.7%
SE Market
Return vs Industry: AMBEA underperformed the Swedish Healthcare industry which returned 11.6% over the past year.
Return vs Market: AMBEA underperformed the Swedish Market which returned 19.6% over the past year.
Shareholder returns
| AMBEA | Industry | Market | |
|---|---|---|---|
| 7 Day | 9.5% | 3.8% | 0.7% |
| 30 Day | 18.7% | 12.6% | 9.5% |
| 90 Day | 5.1% | 11.2% | 9.3% |
| 1 Year | -19.5%-19.5% | 11.1%11.1% | 19.6%17.7% |
| 3 Year | -14.9%-17.5% | 17.0%14.4% | 43.3%27.7% |
| 5 Year | n/a | -14.9%-19.3% | 69.2%36.5% |
Long-Term Price Volatility Vs. Market
How volatile is Ambea's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
We Think Ambea (STO:AMBEA) Is Taking Some Risk With Its Debt2 weeks ago | Simply Wall St
Have Insiders Sold Ambea AB (publ) (STO:AMBEA) Shares Recently?4 weeks ago | Simply Wall St
Ambea (STO:AMBEA) Share Prices Have Dropped 35% In The Last Three YearsValuation
Is Ambea undervalued compared to its fair value and its price relative to the market?
28.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AMBEA (SEK60.2) is trading below our estimate of fair value (SEK83.79)
Significantly Below Fair Value: AMBEA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AMBEA is good value based on its PE Ratio (18.8x) compared to the SE Healthcare industry average (19.1x).
PE vs Market: AMBEA is good value based on its PE Ratio (18.8x) compared to the Swedish market (22.6x).
Price to Earnings Growth Ratio
PEG Ratio: AMBEA is good value based on its PEG Ratio (0.8x)
Price to Book Ratio
PB vs Industry: AMBEA is good value based on its PB Ratio (1.3x) compared to the SE Healthcare industry average (1.5x).
Next Steps
Future Growth
How is Ambea forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
22.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMBEA's forecast earnings growth (22.3% per year) is above the savings rate (0.5%).
Earnings vs Market: AMBEA's earnings (22.3% per year) are forecast to grow faster than the Swedish market (11.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMBEA's revenue (5.5% per year) is forecast to grow faster than the Swedish market (3.4% per year).
High Growth Revenue: AMBEA's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMBEA's Return on Equity is forecast to be low in 3 years time (11.5%).
Next Steps
Past Performance
How has Ambea performed over the past 5 years?
21.1%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AMBEA has high quality earnings.
Growing Profit Margin: AMBEA's current net profit margins (2.7%) are higher than last year (2.2%).
Past Earnings Growth Analysis
Earnings Trend: AMBEA's earnings have grown significantly by 21.1% per year over the past 5 years.
Accelerating Growth: AMBEA's earnings growth over the past year (43.1%) exceeds its 5-year average (21.1% per year).
Earnings vs Industry: AMBEA earnings growth over the past year (43.1%) exceeded the Healthcare industry -11.1%.
Return on Equity
High ROE: AMBEA's Return on Equity (7.1%) is considered low.
Next Steps
Financial Health
How is Ambea's financial position?
Financial Position Analysis
Short Term Liabilities: AMBEA's short term assets (SEK1.6B) do not cover its short term liabilities (SEK3.8B).
Long Term Liabilities: AMBEA's short term assets (SEK1.6B) do not cover its long term liabilities (SEK6.6B).
Debt to Equity History and Analysis
Debt Level: AMBEA's debt to equity ratio (69.1%) is considered high.
Reducing Debt: AMBEA's debt to equity ratio has increased from 45.2% to 69.1% over the past 5 years.
Debt Coverage: AMBEA's debt is well covered by operating cash flow (47.6%).
Interest Coverage: AMBEA's interest payments on its debt are well covered by EBIT (3.3x coverage).
Balance Sheet
Next Steps
Dividend
What is Ambea current dividend yield, its reliability and sustainability?
2.25%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AMBEA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AMBEA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AMBEA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AMBEA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: AMBEA is not paying a notable dividend for the Swedish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AMBEA's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.9yrs
Average management tenure
CEO
Fredrik Gren (52 yo)
8.83yrs
Tenure
kr10,184,658
Compensation
Mr. Fredrik Gren serves as the Chief Executive Officer and President of Ambea AB (Ambea) at Carema Care AB since February 1, 2012. Mr. Gren served as President of Ambea AB. He served as the Chief Executive...
CEO Compensation Analysis
Compensation vs Market: Fredrik's total compensation ($USD1.20M) is above average for companies of similar size in the Swedish market ($USD778.64K).
Compensation vs Earnings: Fredrik's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & President | 8.83yrs | kr10.18m | 0.41% SEK 22.7m | |
| Chief Financial Officer | no data | no data | no data | |
| Head of Group Business Control & Investor Relations | 2.5yrs | no data | no data | |
| Head of Human Resources and Communications | 0.083yr | no data | 0.022% SEK 1.2m | |
| Temporary Head of Nytida | 4yrs | no data | no data | |
| Division Manager of Vardaga | 7.92yrs | no data | 0.39% SEK 21.7m | |
| Head of Quality | no data | no data | no data | |
| Division Manager of Klara | 4.92yrs | no data | 0.0056% SEK 308.8k | |
| Division Manager of Nytida | 2.92yrs | no data | 0.0090% SEK 498.1k | |
| Division Manager of Altiden | 1.92yrs | no data | 0.0021% SEK 117.3k | |
| Division Manager of Stendi | 1.92yrs | no data | no data | |
| Head of Quality & Sustainability | 2.92yrs | no data | 0.0031% SEK 173.2k |
2.9yrs
Average Tenure
54.5yo
Average Age
Experienced Management: AMBEA's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 2.58yrs | kr296.24k | 0.0044% SEK 246.3k | |
| Independent Director | 1.58yrs | kr208.93k | no data | |
| Independent Director | 4.33yrs | kr406.24k | 0.020% SEK 1.1m | |
| Independent Director | 2.58yrs | kr296.24k | no data | |
| Independent Chairperson | 7.92yrs | kr919.25k | 0.45% SEK 24.7m | |
| Director | 1.58yrs | kr252.58k | 0.020% SEK 1.1m | |
| Employee Representative Director | 4.92yrs | no data | no data | |
| Employee Representative Director | 4.92yrs | no data | no data | |
| Employee Representative Director | 4.92yrs | no data | no data | |
| Deputy Employee Representative Director | 4.92yrs | no data | 0.0078% SEK 433.9k | |
| Deputy Employee Representative Director | 2.92yrs | no data | no data |
4.3yrs
Average Tenure
61yo
Average Age
Experienced Board: AMBEA's board of directors are considered experienced (4.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: AMBEA insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Ambea AB (publ)'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Ambea AB (publ)
- Ticker: AMBEA
- Exchange: OM
- Founded: 1996
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: kr5.534b
- Shares outstanding: 94.44m
- Website: https://www.ambea.com
Number of Employees
Location
- Ambea AB (publ)
- Evenemangsgatan 21, 6 tr
- Box 1565
- Solna
- Stockholm County
- 171 29
- Sweden
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 0RNX | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | SEK | Mar 2017 |
| AMBEA | OM (OMX Nordic Exchange Stockholm) | Yes | Ordinary Shares | SE | SEK | Mar 2017 |
| AMBEAS | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | SEK | Mar 2017 |
| 6MA | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Mar 2017 |
Biography
Ambea AB (publ) provides residential care services for people with special needs in Sweden and Norway. The company operates through five segments: Vardaga, Nytida, Stendi, Altiden, and Klara. It offers per...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/12/02 18:39 |
| End of Day Share Price | 2020/12/02 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.